RxE2 will be exhibiting at the DPHARM 2025 US Conference in Philadelphia September 16-17! RxE2 powers community-based clinical trials through technology that expands equitable access to research. By enabling community pharmacies to operate as next-generation clinical trial sites, we recruit, engage, and retain patients where they live and receive care, integrating pharmacists into research to…
We are thrilled to announce that RxE2 has once again been recognized by The Tech Tribune as one of the Best Tech Startups in North Dakota for 2025! This prestigious award marks our fourth consecutive year on this esteemed list, following our consistent inclusion in 2022, 2023, and 2024 The Tech Tribune staff compiles this…
RxE2 is thrilled to be exhibiting at the GCSG 2025 US Conference in San Antonio from April 27–30! We can’t wait to show you how community pharmacists are already transforming clinical trials. We’d love to connect and discuss how we can streamline your trial operations and enhance patient engagement through our innovative solutions. Meet us…
Our team will be at SCOPE 2025 in Florida, February 3 – 6. Our CEO, Gerald, will taking part in a panel titled ‘Bridging the Last Mile: A Hybrid Approach to Patient Access and Retention’, together with our partners at Hawthorne Health and with LabCorp. The Panel will take place on Wednesday, February 5. …
For the third consecutive year we’ve made the list of best tech startups! The Tech Tribune staff has compiled its annual list of the best tech startups in North Dakota. Several factors were considered in their research, including but not limited to: Revenue potential Leadership team Brand/product traction Competitive landscape RxE2 is honored to have…
Meet us at the “Data Driven, Hybrid & Fully Decentralized Clinical Trials” Conference Our team will be at the “Data Driven, Hybrid & Fully Decentralized Clinical Trials” conference which is planned for April 16-17 in Philadelphia at the Hilton Philadelphia @Penns Landing. We’ll be at booth #1! RxE2 CEO Gerald Finken Joins Panel Discussion Gerald…
Join our session RxE2 CEO, Gerald Finken, will be taking part in a panel titled: “The Integration of Clinical Trials and Clinical Care: A Revolution in the Participant and Sponsor Experience or an Implementation Nightmare? Or Both?” When & Where Monday, October 23, 2023 | 7:00 AM – 9:00 AM ET | Location:308 AB West Meet…
For the second consecutive year we’ve made the list of best tech startups! The Tech Tribune staff has compiled a list of the best tech startups in North Dakota. Several factors were considered in their research, including but not limited to: Revenue potential Leadership team Brand/product traction Competitive landscape RxE2 is honored to have been…
Fargo, ND August 17 2023 – RxE2 announces the appointment of Doug Liberi as VP of Business Development and Sales. In his role as VP of business development, Mr. Liberi will be in charge of category creation and market expansion for RxE2, leading the company’s sales team strategically. “I am happy Doug has agreed to…
Fargo, ND, June 15, 2023 – This is the third year in which RxE2, led by CEO and two-time USA Cycling Masters National Cycling Champion, Gerald Finken, pledges $27,500 the NorthStar Cycling Club. “For over ten years NorthStar Development Cycling has shared the thrill of competitive cycling with scores of school-aged kids. Gerald Finken has…